Counseling and DNA Testing for Individuals Perceived to Be Genetically Predisposed to Melanoma: A Consensus Statement of the Melanoma Genetics Consortium
- 1 October 1999
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 17 (10) , 3245-3251
- https://doi.org/10.1200/jco.1999.17.10.3245
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression PathwaysPublished by Elsevier ,1998
- The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53Cell, 1998
- Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19Cell, 1997
- Screening for CDKN2A mutations in hereditary melanoma.JNCI Journal of the National Cancer Institute, 1997
- Clinically Recognized Dysplastic NeviJAMA, 1997
- Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: A case-control study in new South Wales, AustraliaInternational Journal of Cancer, 1996
- Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4MutationsNew England Journal of Medicine, 1995
- Risk of cutaneous melanoma associated with a family history of the diseaseInternational Journal of Cancer, 1995
- Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studiesInternational Journal of Cancer, 1995
- How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?Journal of the American Academy of Dermatology, 1993